Lv5
1240 积分 2025-02-12 加入
Pericancerous cross-presentation to cytotoxic T lymphocytes impairs immunotherapeutic efficacy in hepatocellular carcinoma
16天前
已完结
Progenitor-like exhausted SPRY1+CD8+ T cells potentiate responsiveness to neoadjuvant PD-1 blockade in esophageal squamous cell carcinoma
16天前
已完结
Distinct cellular mechanisms underlie chemotherapies and PD-L1 blockade combinations in triple-negative breast cancer
16天前
已完结
Spatiotemporal single-cell analysis decodes cellular dynamics underlying different responses to immunotherapy in colorectal cancer
16天前
已完结
Metronomic chemotherapy plus anti-PD-1 in metastatic breast cancer: a Bayesian adaptive randomized phase 2 trial
24天前
已完结
Metronomic chemotherapy plus anti-PD-1 in metastatic breast cancer: a Bayesian adaptive randomized phase 2 trial
29天前
已完结
Histological signatures map anti-fibrotic factors in mouse and human lungs
30天前
已完结
Distinct CD8+ T cell dynamics associate with response to neoadjuvant cancer immunotherapies
1个月前
已完结
Tertiary lymphoid structures in cancer
1个月前
已完结
Siglec-9 acts as an immune-checkpoint molecule on macrophages in glioblastoma, restricting T-cell priming and immunotherapy response
1个月前
已完结
皖公网安备34019202002308
